Recalcitrant and recurrent bacterial folliculitis during anti-IL 17 therapy in a psoriatic patient

G Ital Dermatol Venereol. 2020 Apr;155(2):247-248. doi: 10.23736/S0392-0488.18.05993-X. Epub 2018 Jul 18.

Authors

Lidia Sacchelli¹, Francesca Ferrara², Federico Tartari², Annalisa Patrizi², Federico Bardazzi²

Affiliations

¹ Unit of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy - [email protected].
² Unit of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

PMID: 30019574
DOI: 10.23736/S0392-0488.18.05993-X

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / adverse effects*
Folliculitis / chemically induced
Folliculitis / diagnosis*
Humans
Interleukin-17 / antagonists & inhibitors
Male
Psoriasis / drug therapy*
Recurrence
Skin Diseases, Bacterial / chemically induced
Skin Diseases, Bacterial / diagnosis*

Substances

Antibodies, Monoclonal, Humanized
IL17A protein, human
Interleukin-17
secukinumab